Obtenez 3 mois à 0,99 $/mois + 20 $ de crédit Audible

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Parkinson's and the B1 Therapy

Parkinson's and the B1 Therapy

Aperçu
En profiter Essayer pour 0,00 $
L'offre prend fin le 1 décembre 2025 à 23 h 59, HP.
Abonnez-vous à Audible pour 0,99 $/mois pendant les 3 premiers mois et obtenez un crédit de 20 $ en prime sur Audible.ca. La notification de crédit sera envoyée par courriel.
1 nouveauté ou titre populaire à choisir chaque mois – ce titre vous appartiendra.
L'écoute illimitée des milliers de livres audio, de balados et de titres originaux inclus.
L'abonnement se renouvelle automatiquement au tarif de 0,99 $/mois pendant 3 mois, et au tarif de 14,95 $/mois ensuite. Annulation possible à tout moment.
Choisissez 1 livre audio par mois dans notre incomparable catalogue.
Écoutez à volonté des milliers de livres audio, de livres originaux et de balados.
L'abonnement Premium Plus se renouvelle automatiquement au tarif de 14,95 $/mois + taxes applicables après 30 jours. Annulation possible à tout moment.

Parkinson's and the B1 Therapy

Auteur(s): Daphne Bryan PhD
Narrateur(s): Anna Crowe
En profiter Essayer pour 0,00 $

14,95 $/mois après 3 mois. L'offre prend fin le 1 décembre 2025 à 23 h 59, HP. Annulation possible à tout moment.

14,95$ par mois après 30 jours. Annulable en tout temps.

Acheter pour 8,71 $

Acheter pour 8,71 $

À propos de cet audio

In 2011, the Italian neurologist Dr Antonio Costantini began treating his Parkinson’s patients with high doses of B1. As a result, their symptoms improved by up to 70 percent with no obvious progression in the disease over the five years he worked with them. Yet there is still a lack of awareness about this valuable therapy amongst doctors and Parkinson’s nurses.

This book is intended for people with Parkinson’s and their health professionals. It presents theories and hypotheses to explain the substantial effect thiamine has on the brain, discusses the available research which has studied the effect of high doses of B1 on Parkinson’s patients, and details the protocol, as we currently understand it, for patients and doctors who wish to use the therapy.

Parkinson’s is a degenerative disease and consequently there is a sense of urgency for neurologists, doctors, and Parkinson’s nurses to acquaint themselves with this therapy. This treatment is immediately available, relatively inexpensive and safe, and for many of us has improved our lives significantly.

Sadly, in 2020 Dr. Costantini died from Covid-19. However, his colleagues, wishing to continue his work, have designed a rigorous research project to understand more about the effect of high doses of thiamine on the Parkinson’s brain. This in-depth research is needed before the therapy will be adopted by mainstream medicine. The research team have, however, been unable to procure funding to start this important study.

©2022 Daphne Bryan PhD (P)2023 Daphne Bryan PhD
Médecine alternative Troubles et maladies Santé Exercice physique Cerveau humain Médecine
Pas encore de commentaire